|Articles|May 1, 2005
- Pharmaceutical Executive-05-01-2005
- Volume 0
- Issue 0
TOC
TOC
Advertisement
Articles in this issue
over 20 years ago
Pharm Exec Ad Starsover 20 years ago
Elephant or Specialist?over 20 years ago
Global Report: Iron Fistover 20 years ago
Washington Report: The Pendulum Swingsover 20 years ago
What Does It Take to be a Global Leader in Trainingover 20 years ago
Unleash the Tabletsover 20 years ago
Eisai's New Leadershipover 20 years ago
Superstar Selectionover 20 years ago
TOCover 20 years ago
Professional Persuasion:101Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
3
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
4
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
5
